{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:45:10Z","timestamp":1794638710732,"version":"4.9.1"},"publisher-location":"Singapore","reference-count":79,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811560811","type":"print"},{"value":"9789811560828","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-981-15-6082-8_2","type":"book-chapter","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T02:58:13Z","timestamp":1595473093000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cholesteryl Ester Transfer Protein and Lipid Metabolism and Cardiovascular Diseases"],"prefix":"10.1007","author":[{"given":"Helena C. F.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena F.","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1073\/pnas.75.7.3445","volume":"75","author":"T Chajek","year":"1978","unstructured":"Chajek T, Fielding CJ (1978) Isolation and characterization of a human serum cholesteryl ester transfer protein. Proc Natl Acad Sci U S A 75:3445\u20133449","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/0005-2760(78)90163-7","volume":"530","author":"NM Pattnaik","year":"1978","unstructured":"Pattnaik NM, Montes A, Hughes LB, Zilversmit DB (1978) Cholesteryl ester exchange protein in human plasma isolation and characterization. Biochim Biophys Acta 530:428\u2013438","journal-title":"Biochim Biophys Acta"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0305-0491(82)90252-8","volume":"71","author":"YC Ha","year":"1982","unstructured":"Ha YC, Barter PJ (1982) Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol B 71:265\u2013269","journal-title":"Comp Biochem Physiol B"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1248\/bpb.24.579","volume":"24","author":"K Tsutsumi","year":"2001","unstructured":"Tsutsumi K, Hagi A, Inoue Y (2001) The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals. Biol Pharm Bull 24:579\u2013581","journal-title":"Biol Pharm Bull"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/S0021-9258(18)61650-3","volume":"262","author":"CB Hesler","year":"1987","unstructured":"Hesler CB, Swenson TL, Tall AR (1987) Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem 262:2275\u20132282","journal-title":"J Biol Chem"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/327632a0","volume":"327","author":"D Drayna","year":"1987","unstructured":"Drayna D et al (1987) Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327:632\u2013634","journal-title":"Nature"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1021\/bi00458a004","volume":"29","author":"LB Agellon","year":"1990","unstructured":"Agellon LB et al (1990) Organization of the human cholesteryl ester transfer protein gene. Biochemistry 29:1372\u20131376","journal-title":"Biochemistry"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/iub.448","volume":"63","author":"HCF Oliveira","year":"2011","unstructured":"Oliveira HCF, de Faria EC (2011) Cholesteryl ester transfer protein: the controversial relation to atherosclerosis and emerging new biological roles. IUBMB Life 63:248\u2013257","journal-title":"IUBMB Life"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nsmb1197","volume":"14","author":"X Qiu","year":"2007","unstructured":"Qiu X et al (2007) Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat Struct Mol Biol 14:106\u2013113","journal-title":"Nat Struct Mol Biol"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1194\/jlr.R027011","volume":"53","author":"MA Charles","year":"2012","unstructured":"Charles MA, Kane JP (2012) New molecular insights into CETP structure and function: a review. J Lipid Res 53:1451\u20131458","journal-title":"J Lipid Res"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1021\/bi00123a021","volume":"31","author":"A Inazu","year":"1992","unstructured":"Inazu A et al (1992) Alternative splicing of the mRNA encoding the human cholesteryl ester transfer protein. Biochemistry 31:2352\u20132358","journal-title":"Biochemistry"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"16891","DOI":"10.1016\/S0021-9258(19)85278-X","volume":"268","author":"E Quinet","year":"1993","unstructured":"Quinet E, Yang TP, Marinos C, Tall A (1993) Inhibition of the cellular secretion of cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA. J Biol Chem 268:16891\u201316894","journal-title":"J Biol Chem"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/jlr.M800078-JLR200","volume":"49","author":"ME Lira","year":"2008","unstructured":"Lira ME, Loomis AK, Paciga SA, Lloyd DB, Thompson JF (2008) Expression of CETP and of splice variants induces the same level of ER stress despite secretion efficiency differences. J Lipid Res 49:1955\u20131962","journal-title":"J Lipid Res"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bbalip.2016.01.016","volume":"1861","author":"V Alva","year":"2016","unstructured":"Alva V, Lupas AN (2016) The TULIP superfamily of eukaryotic lipid-binding proteins as a mediator of lipid sensing and transport. Biochim Biophys Acta 1861:913\u2013923","journal-title":"Biochim Biophys Acta"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.bbamcr.2017.05.019","volume":"1864","author":"LH Wong","year":"2017","unstructured":"Wong LH, Levine TP (2017) Tubular lipid binding proteins (TULIPs) growing everywhere. Biochim Biophys Acta Mol Cell Res 1864:1439\u20131449","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","volume":"1","author":"GJ Miller","year":"1975","unstructured":"Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet Lond Engl 1:16\u201319","journal-title":"Lancet Lond Engl"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","volume":"62","author":"T Gordon","year":"1977","unstructured":"Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707\u2013714","journal-title":"Am J Med"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","volume":"9","author":"JA Glomset","year":"1968","unstructured":"Glomset JA (1968) The plasma lecithins: cholesterol acyltransferase reaction. J Lipid Res 9:155\u2013167","journal-title":"J Lipid Res"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"10796","DOI":"10.1016\/S0021-9258(18)99088-5","volume":"266","author":"LB Agellon","year":"1991","unstructured":"Agellon LB et al (1991) Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 266:10796\u201310801","journal-title":"J Biol Chem"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1172\/JCI115993","volume":"90","author":"XC Jiang","year":"1992","unstructured":"Jiang XC, Agellon LB, Walsh A, Breslow JL, Tall A (1992) Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. J Clin Invest 90:1290\u20131295","journal-title":"J Clin Invest"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/364073a0","volume":"364","author":"KR Marotti","year":"1993","unstructured":"Marotti KR et al (1993) Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364:73\u201375","journal-title":"Nature"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg L et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics MCP 13:397\u2013406","journal-title":"Mol Cell Proteomics MCP"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1172\/JCI115169","volume":"87","author":"E Quinet","year":"1991","unstructured":"Quinet E, Tall A, Ramakrishnan R, Rudel L (1991) Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 87:1559\u20131566","journal-title":"J Clin Invest"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/hep.27985","volume":"62","author":"Y Wang","year":"2015","unstructured":"Wang Y et al (2015) Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells. Hepatol Baltim Md 62:1710\u20131722","journal-title":"Hepatol Baltim Md"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"31831","DOI":"10.1074\/jbc.271.50.31831","volume":"271","author":"HC Oliveira","year":"1996","unstructured":"Oliveira HC et al (1996) Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5\u2032-distal sequences. Cis-acting sequences mapped in transgenic mice. J Biol Chem 271:31831\u201331838","journal-title":"J Biol Chem"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1172\/JCI8573","volume":"105","author":"Y Luo","year":"2000","unstructured":"Luo Y, Tall AR (2000) Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest 105:513\u2013520","journal-title":"J Clin Invest"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1053\/meta.2001.22514","volume":"50","author":"JA Berti","year":"2001","unstructured":"Berti JA et al (2001) Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice. Metabolism 50:530\u2013536","journal-title":"Metabolism"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jnutbio.2014.02.008","volume":"25","author":"HF Raposo","year":"2014","unstructured":"Raposo HF, Patr\u00edcio PR, Sim\u00f5es MC, Oliveira HCF (2014) Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene. J Nutr Biochem 25:669\u2013674","journal-title":"J Nutr Biochem"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1172\/JCI117832","volume":"95","author":"L Masucci-Magoulas","year":"1995","unstructured":"Masucci-Magoulas L et al (1995) Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. J Clin Invest 95:1587\u20131594","journal-title":"J Clin Invest"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1194\/jlr.M300036-JLR200","volume":"44","author":"JA Berti","year":"2003","unstructured":"Berti JA et al (2003) Cholesteryl ester transfer protein expression is down-regulated in hyperinsulinemic transgenic mice. J Lipid Res 44:1870\u20131876","journal-title":"J Lipid Res"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/01.ATV.19.4.1105","volume":"19","author":"AS Plump","year":"1999","unstructured":"Plump AS et al (1999) Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler Thromb Vasc Biol 19:1105\u20131110","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1161\/01.ATV.0000243925.65265.3c","volume":"26","author":"M Westerterp","year":"2006","unstructured":"Westerterp M et al (2006) Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice. Arterioscler Thromb Vasc Biol 26:2552\u20132559","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.RES.0000260202.79927.4f","volume":"100","author":"M Van Eck","year":"2007","unstructured":"Van Eck M et al (2007) Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice. Circ Res 100:678\u2013685","journal-title":"Circ Res"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1172\/JCI118255","volume":"96","author":"T Hayek","year":"1995","unstructured":"Hayek T et al (1995) Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 96:2071\u20132074","journal-title":"J Clin Invest"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"36912","DOI":"10.1074\/jbc.274.52.36912","volume":"274","author":"B F\u00f6ger","year":"1999","unstructured":"F\u00f6ger B et al (1999) Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J Biol Chem 274:36912\u201336920","journal-title":"J Biol Chem"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1590\/S0100-879X2005000300010","volume":"38","author":"JA Berti","year":"2005","unstructured":"Berti JA, de Faria EC, Oliveira HCF (2005) Atherosclerosis in aged mice over-expressing the reverse cholesterol transport genes. Braz J Med Biol Res Rev Bras Pesqui Medicas E Biol 38:391\u2013398","journal-title":"Braz J Med Biol Res Rev Bras Pesqui Medicas E Biol"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1194\/jlr.M100440-JLR200","volume":"44","author":"PM Cazita","year":"2003","unstructured":"Cazita PM et al (2003) Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice. J Lipid Res 44:33\u201340","journal-title":"J Lipid Res"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1194\/jlr.M600135-JLR200","volume":"47","author":"AC Casquero","year":"2006","unstructured":"Casquero AC et al (2006) Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice. J Lipid Res 47:1526\u20131534","journal-title":"J Lipid Res"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S0022-2275(20)30460-0","volume":"43","author":"Y Kako","year":"2002","unstructured":"Kako Y, Mass\u00e9 M, Huang L-S, Tall AR, Goldberg IJ (2002) Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice. J Lipid Res 43:872\u2013877","journal-title":"J Lipid Res"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/01.ATV.0000080687.94313.67","volume":"23","author":"PS MacLean","year":"2003","unstructured":"MacLean PS et al (2003) Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db\/db mice. Arterioscler Thromb Vasc Biol 23:1412\u20131415","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/01.ATV.0000259357.42089.dc","volume":"27","author":"C Harder","year":"2007","unstructured":"Harder C, Lau P, Meng A, Whitman SC, McPherson R (2007) Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice. Arterioscler Thromb Vasc Biol 27:858\u2013864","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"17227","DOI":"10.1074\/jbc.M111.220483","volume":"286","author":"M El Bouhassani","year":"2011","unstructured":"El Bouhassani M et al (2011) Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis. J Biol Chem 286:17227\u201317238","journal-title":"J Biol Chem"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0021-9150(85)90064-4","volume":"58","author":"J Koizumi","year":"1985","unstructured":"Koizumi J et al (1985) Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis 58:175\u2013186","journal-title":"Atherosclerosis"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0021-9150(00)00574-8","volume":"152","author":"S Yamashita","year":"2000","unstructured":"Yamashita S et al (2000) Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. Atherosclerosis 152:271\u2013285","journal-title":"Atherosclerosis"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1172\/JCI118751","volume":"97","author":"S Zhong","year":"1996","unstructured":"Zhong S et al (1996) Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97:2917\u20132923","journal-title":"J Clin Invest"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5551\/jat.11.110","volume":"11","author":"M Nagano","year":"2004","unstructured":"Nagano M et al (2004) Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb 11:110\u2013121","journal-title":"J Atheroscler Thromb"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/01.ATV.20.5.1323","volume":"20","author":"JM Ordovas","year":"2000","unstructured":"Ordovas JM et al (2000) Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20:1323\u20131329","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR48","doi-asserted-by":"crossref","unstructured":"Quint\u00e3o ECR (2010) Letter by Quintao regarding article, \u2018Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community\u2019. Circulation 122:e420; author reply e421","DOI":"10.1161\/CIRCULATIONAHA.109.930842"},{"key":"2_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000160","volume":"93","author":"M Cao","year":"2014","unstructured":"Cao M, Zhou Z-W, Fang B-J, Zhao C-G, Zhou D (2014) Meta-analysis of cholesteryl ester transfer protein TaqIB polymorphism and risk of myocardial infarction. Medicine (Baltimore) 93:e160","journal-title":"Medicine (Baltimore)"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1001\/jama.299.23.2777","volume":"299","author":"A Thompson","year":"2008","unstructured":"Thompson A et al (2008) Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 299:2777\u20132788","journal-title":"JAMA"},{"key":"2_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088118","volume":"9","author":"Q Wang","year":"2014","unstructured":"Wang Q et al (2014) Seven functional polymorphisms in the CETP gene and myocardial infarction risk: a meta-analysis and meta-regression. PloS One 9:e88118","journal-title":"PloS One"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1161\/CIRCULATIONAHA.107.761965","volume":"117","author":"W de Haan","year":"2008","unstructured":"de Haan W et al (2008) Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin. Circulation 117:2515\u20132522","journal-title":"Circulation"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/SHK.0b013e31816e30fd","volume":"30","author":"PM Cazita","year":"2008","unstructured":"Cazita PM, Barbeiro DF, Moretti AIS, Quint\u00e3o ECR, Soriano FG (2008) Human cholesteryl ester transfer protein expression enhances the mouse survival rate in an experimental systemic inflammation model: a novel role for CETP. Shock Augusta Ga 30:590\u2013595","journal-title":"Shock Augusta Ga"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"1784014","DOI":"10.1155\/2016\/1784014","volume":"2016","author":"TM Venancio","year":"2016","unstructured":"Venancio TM et al (2016) CETP lowers TLR4 expression which attenuates the inflammatory response induced by LPS and polymicrobial sepsis. Mediators Inflamm 2016:1784014","journal-title":"Mediators Inflamm"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","volume":"357","author":"PJ Barter","year":"2007","unstructured":"Barter PJ et al (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357:2109\u20132122","journal-title":"N Engl J Med"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2362.2010.02269.x","volume":"40","author":"CMC Grion","year":"2010","unstructured":"Grion CMC et al (2010) Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients. Eur J Clin Invest 40:330\u2013338","journal-title":"Eur J Clin Invest"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1164\/rccm.201806-1157OC","volume":"199","author":"M Trinder","year":"2019","unstructured":"Trinder M et al (2019) Cholesteryl ester transfer protein influences high-density lipoprotein levels and survival in sepsis. Am J Respir Crit Care Med 199:854\u2013862","journal-title":"Am J Respir Crit Care Med"},{"key":"2_CR58","doi-asserted-by":"publisher","unstructured":"Blauw LL, Wang Y, Willems van Dijk K, Rensen PCN (2020) A novel role for CETP as immunological gatekeeper: raising HDL to cure sepsis? Trends Endocrinol Metab. https:\/\/doi.org\/10.1016\/j.tem.2020.01.003","DOI":"10.1016\/j.tem.2020.01.003"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0021-9150(01)00490-7","volume":"159","author":"Z Zhang","year":"2001","unstructured":"Zhang Z et al (2001) Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport. Atherosclerosis 159:67\u201375","journal-title":"Atherosclerosis"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"26534","DOI":"10.1074\/jbc.M103624200","volume":"276","author":"L Izem","year":"2001","unstructured":"Izem L, Morton RE (2001) Cholesteryl ester transfer protein biosynthesis and cellular cholesterol homeostasis are tightly interconnected. J Biol Chem 276:26534\u201326541","journal-title":"J Biol Chem"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"21856","DOI":"10.1074\/jbc.M701075200","volume":"282","author":"L Izem","year":"2007","unstructured":"Izem L, Morton RE (2007) Possible role for intracellular cholesteryl ester transfer protein in adipocyte lipid metabolism and storage. J Biol Chem 282:21856\u201321865","journal-title":"J Biol Chem"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1194\/jlr.M056481","volume":"56","author":"DJ Greene","year":"2015","unstructured":"Greene DJ, Izem L, Morton RE (2015) Defective triglyceride biosynthesis in CETP-deficient SW872 cells. J Lipid Res 56:1669\u20131678","journal-title":"J Lipid Res"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1194\/jlr.m053678","volume":"56","author":"L Izem","year":"2015","unstructured":"Izem L, Greene DJ, Bialkowska K, Morton RE (2015) Overexpression of full-length cholesteryl ester transfer protein in SW872 cells reduces lipid accumulation. J Lipid Res 56:515\u2013525","journal-title":"J Lipid Res"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1194\/jlr.M600153-JLR200","volume":"47","author":"H Zhou","year":"2006","unstructured":"Zhou H et al (2006) Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism. J Lipid Res 47:2011\u20132019","journal-title":"J Lipid Res"},{"key":"2_CR65","doi-asserted-by":"publisher","unstructured":"Izem L, Liu Y, Morton RE (2020) Exon 9-deleted CETP inhibits full length-CETP synthesis and promotes cellular triglyceride storage. J Lipid Res. https:\/\/doi.org\/10.1194\/jlr.RA120000583","DOI":"10.1194\/jlr.RA120000583"},{"key":"2_CR66","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1074\/jbc.273.9.5033","volume":"273","author":"M Sugano","year":"1998","unstructured":"Sugano M et al (1998) Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem 273:5033\u20135036","journal-title":"J Biol Chem"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1161\/01.ATV.20.9.2106","volume":"20","author":"CW Rittershaus","year":"2000","unstructured":"Rittershaus CW et al (2000) Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol 20:2106\u20132112","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa070635","volume":"356","author":"SE Nissen","year":"2007","unstructured":"Nissen SE et al (2007) Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 356:1304\u20131316","journal-title":"N Engl J Med"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","volume":"367","author":"GG Schwartz","year":"2012","unstructured":"Schwartz GG et al (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 367:2089\u20132099","journal-title":"N Engl J Med"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","volume":"376","author":"AM Lincoff","year":"2017","unstructured":"Lincoff AM et al (2017) Evacetrapib and cardiovascular outcomes in high-risk vascular disease. N Engl J Med 376:1933\u20131942","journal-title":"N Engl J Med"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","volume":"377","author":"HPS3\/TIMI55\u2013REVEAL Collaborative Group","year":"2017","unstructured":"HPS3\/TIMI55\u2013REVEAL Collaborative Group et al (2017) Effects of anacetrapib in patients with atherosclerotic vascular disease. N Engl J Med 377:1217\u20131227","journal-title":"N Engl J Med"},{"key":"2_CR72","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/cpt.700","volume":"102","author":"R Krishna","year":"2017","unstructured":"Krishna R et al (2017) Chronic administration of anacetrapib is associated with accumulation in adipose and slow elimination. Clin Pharmacol Ther 102:832\u2013840","journal-title":"Clin Pharmacol Ther"},{"key":"2_CR73","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.diabet.2018.02.005","volume":"44","author":"W Masson","year":"2018","unstructured":"Masson W et al (2018) Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk. Diabetes Metab 44:508\u2013513","journal-title":"Diabetes Metab"},{"key":"2_CR74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41569-019-0157-6","volume":"16","author":"MV Holmes","year":"2019","unstructured":"Holmes MV, Ala-Korpela M (2019) What is \u2018LDL cholesterol\u2019? Nat Rev Cardiol 16:197\u2013198","journal-title":"Nat Rev Cardiol"},{"key":"2_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000572","volume":"17","author":"J Kettunen","year":"2019","unstructured":"Kettunen J et al (2019) Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition. PLoS Biol 17:e3000572","journal-title":"PLoS Biol"},{"key":"2_CR76","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI87364","volume":"126","author":"JS Millar","year":"2016","unstructured":"Millar JS et al (2016) Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects. J Clin Invest 126:1603\u20131604","journal-title":"J Clin Invest"},{"key":"2_CR77","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/bcp.12380","volume":"78","author":"J Ford","year":"2014","unstructured":"Ford J et al (2014) Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. Br J Clin Pharmacol 78:498\u2013508","journal-title":"Br J Clin Pharmacol"},{"key":"2_CR78","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(15)60158-1","volume":"386","author":"GK Hovingh","year":"2015","unstructured":"Hovingh GK et al (2015) Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Lond Engl 386:452\u2013460","journal-title":"Lancet Lond Engl"},{"key":"2_CR79","doi-asserted-by":"crossref","first-page":"1137.e3","DOI":"10.1016\/j.jacl.2016.06.006","volume":"10","author":"JC van Capelleveen","year":"2016","unstructured":"van Capelleveen JC et al (2016) Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses. J Clin Lipidol 10:1137.e3\u20131144.e3","journal-title":"J Clin Lipidol"}],"container-title":["Advances in Experimental Medicine and Biology","Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-6082-8_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T12:09:09Z","timestamp":1649938149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-15-6082-8_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9789811560811","9789811560828"],"references-count":79,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-6082-8_2","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-981-15-6082-8","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"24 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}